nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000884	0.000884	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Cisplatin—testicular cancer	0.000883	0.000883	CcSEcCtD
Fondaparinux sodium—Bronchitis—Epirubicin—testicular cancer	0.000882	0.000882	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Dactinomycin—testicular cancer	0.00088	0.00088	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000877	0.000877	CcSEcCtD
Fondaparinux sodium—Vomiting—Bleomycin—testicular cancer	0.000876	0.000876	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Methotrexate—testicular cancer	0.000874	0.000874	CcSEcCtD
Fondaparinux sodium—Infestation—Methotrexate—testicular cancer	0.000874	0.000874	CcSEcCtD
Fondaparinux sodium—Hypotension—Etoposide—testicular cancer	0.000869	0.000869	CcSEcCtD
Fondaparinux sodium—Rash—Bleomycin—testicular cancer	0.000869	0.000869	CcSEcCtD
Fondaparinux sodium—Gastritis—Doxorubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Fondaparinux sodium—Pain—Cisplatin—testicular cancer	0.000869	0.000869	CcSEcCtD
Fondaparinux sodium—Dermatitis—Bleomycin—testicular cancer	0.000868	0.000868	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Ifosfamide—testicular cancer	0.000868	0.000868	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000866	0.000866	CcSEcCtD
Fondaparinux sodium—Renal failure—Methotrexate—testicular cancer	0.000859	0.000859	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—testicular cancer	0.000854	0.000854	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—testicular cancer	0.000849	0.000849	CcSEcCtD
Fondaparinux sodium—Asthenia—Ifosfamide—testicular cancer	0.000845	0.000845	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Cisplatin—testicular cancer	0.000837	0.000837	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Etoposide—testicular cancer	0.000835	0.000835	CcSEcCtD
Fondaparinux sodium—Pruritus—Ifosfamide—testicular cancer	0.000833	0.000833	CcSEcCtD
Fondaparinux sodium—Haematuria—Methotrexate—testicular cancer	0.000833	0.000833	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Etoposide—testicular cancer	0.00083	0.00083	CcSEcCtD
Fondaparinux sodium—Somnolence—Etoposide—testicular cancer	0.000827	0.000827	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Methotrexate—testicular cancer	0.000826	0.000826	CcSEcCtD
Fondaparinux sodium—Epistaxis—Methotrexate—testicular cancer	0.000824	0.000824	CcSEcCtD
Fondaparinux sodium—Nausea—Bleomycin—testicular cancer	0.000819	0.000819	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Epirubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Fondaparinux sodium—Infestation—Epirubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Fondaparinux sodium—Vomiting—Dactinomycin—testicular cancer	0.000817	0.000817	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—testicular cancer	0.000816	0.000816	CcSEcCtD
Fondaparinux sodium—Rash—Dactinomycin—testicular cancer	0.000811	0.000811	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Etoposide—testicular cancer	0.000809	0.000809	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Ifosfamide—testicular cancer	0.000806	0.000806	CcSEcCtD
Fondaparinux sodium—Renal failure—Epirubicin—testicular cancer	0.000804	0.000804	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Etoposide—testicular cancer	0.000803	0.000803	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Cisplatin—testicular cancer	0.000803	0.000803	CcSEcCtD
Fondaparinux sodium—Fatigue—Etoposide—testicular cancer	0.000802	0.000802	CcSEcCtD
Fondaparinux sodium—Pain—Etoposide—testicular cancer	0.000796	0.000796	CcSEcCtD
Fondaparinux sodium—Constipation—Etoposide—testicular cancer	0.000796	0.000796	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Epirubicin—testicular cancer	0.000795	0.000795	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Methotrexate—testicular cancer	0.000788	0.000788	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Methotrexate—testicular cancer	0.000784	0.000784	CcSEcCtD
Fondaparinux sodium—Haematuria—Epirubicin—testicular cancer	0.00078	0.00078	CcSEcCtD
Fondaparinux sodium—Dizziness—Ifosfamide—testicular cancer	0.000779	0.000779	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Epirubicin—testicular cancer	0.000773	0.000773	CcSEcCtD
Fondaparinux sodium—Epistaxis—Epirubicin—testicular cancer	0.000771	0.000771	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Etoposide—testicular cancer	0.000767	0.000767	CcSEcCtD
Fondaparinux sodium—Nausea—Dactinomycin—testicular cancer	0.000764	0.000764	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Etoposide—testicular cancer	0.000761	0.000761	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Fondaparinux sodium—Vomiting—Ifosfamide—testicular cancer	0.000749	0.000749	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Cisplatin—testicular cancer	0.000748	0.000748	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—testicular cancer	0.000744	0.000744	CcSEcCtD
Fondaparinux sodium—Rash—Ifosfamide—testicular cancer	0.000743	0.000743	CcSEcCtD
Fondaparinux sodium—Dermatitis—Ifosfamide—testicular cancer	0.000742	0.000742	CcSEcCtD
Fondaparinux sodium—Urticaria—Etoposide—testicular cancer	0.000739	0.000739	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Epirubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Etoposide—testicular cancer	0.000736	0.000736	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Etoposide—testicular cancer	0.000736	0.000736	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—testicular cancer	0.000735	0.000735	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Epirubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Epirubicin—testicular cancer	0.00073	0.00073	CcSEcCtD
Fondaparinux sodium—Asthenia—Cisplatin—testicular cancer	0.000729	0.000729	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Epirubicin—testicular cancer	0.000723	0.000723	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—testicular cancer	0.000721	0.000721	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000716	0.000716	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—testicular cancer	0.000714	0.000714	CcSEcCtD
Fondaparinux sodium—Angiopathy—Methotrexate—testicular cancer	0.000712	0.000712	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Methotrexate—testicular cancer	0.000709	0.000709	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Methotrexate—testicular cancer	0.000707	0.000707	CcSEcCtD
Fondaparinux sodium—Nausea—Ifosfamide—testicular cancer	0.0007	0.0007	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Cisplatin—testicular cancer	0.000695	0.000695	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Etoposide—testicular cancer	0.000686	0.000686	CcSEcCtD
Fondaparinux sodium—Malnutrition—Methotrexate—testicular cancer	0.000683	0.000683	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—testicular cancer	0.000683	0.000683	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—testicular cancer	0.000681	0.000681	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—testicular cancer	0.000679	0.000679	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—testicular cancer	0.000676	0.000676	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—testicular cancer	0.000669	0.000669	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Methotrexate—testicular cancer	0.000669	0.000669	CcSEcCtD
Fondaparinux sodium—Asthenia—Etoposide—testicular cancer	0.000668	0.000668	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—testicular cancer	0.000666	0.000666	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Fondaparinux sodium—Back pain—Methotrexate—testicular cancer	0.000661	0.000661	CcSEcCtD
Fondaparinux sodium—Pruritus—Etoposide—testicular cancer	0.000658	0.000658	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—testicular cancer	0.000656	0.000656	CcSEcCtD
Fondaparinux sodium—Vomiting—Cisplatin—testicular cancer	0.000646	0.000646	CcSEcCtD
Fondaparinux sodium—Vision blurred—Methotrexate—testicular cancer	0.000644	0.000644	CcSEcCtD
Fondaparinux sodium—Rash—Cisplatin—testicular cancer	0.00064	0.00064	CcSEcCtD
Fondaparinux sodium—Dermatitis—Cisplatin—testicular cancer	0.00064	0.00064	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—testicular cancer	0.000639	0.000639	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Etoposide—testicular cancer	0.000637	0.000637	CcSEcCtD
Fondaparinux sodium—Anaemia—Methotrexate—testicular cancer	0.000631	0.000631	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—testicular cancer	0.00063	0.00063	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—testicular cancer	0.00063	0.00063	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—testicular cancer	0.000618	0.000618	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Fondaparinux sodium—Dizziness—Etoposide—testicular cancer	0.000615	0.000615	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Fondaparinux sodium—Vertigo—Methotrexate—testicular cancer	0.000614	0.000614	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—testicular cancer	0.000607	0.000607	CcSEcCtD
Fondaparinux sodium—Nausea—Cisplatin—testicular cancer	0.000603	0.000603	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Fondaparinux sodium—Cough—Methotrexate—testicular cancer	0.000596	0.000596	CcSEcCtD
Fondaparinux sodium—Convulsion—Methotrexate—testicular cancer	0.000592	0.000592	CcSEcCtD
Fondaparinux sodium—Vomiting—Etoposide—testicular cancer	0.000592	0.000592	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—testicular cancer	0.000591	0.000591	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—testicular cancer	0.000591	0.000591	CcSEcCtD
Fondaparinux sodium—Rash—Etoposide—testicular cancer	0.000587	0.000587	CcSEcCtD
Fondaparinux sodium—Dermatitis—Etoposide—testicular cancer	0.000586	0.000586	CcSEcCtD
Fondaparinux sodium—Headache—Etoposide—testicular cancer	0.000583	0.000583	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—testicular cancer	0.000583	0.000583	CcSEcCtD
Fondaparinux sodium—Chest pain—Methotrexate—testicular cancer	0.000581	0.000581	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—testicular cancer	0.000579	0.000579	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000577	0.000577	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—testicular cancer	0.000574	0.000574	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—testicular cancer	0.000573	0.000573	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—testicular cancer	0.000572	0.000572	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—testicular cancer	0.000565	0.000565	CcSEcCtD
Fondaparinux sodium—Confusional state—Methotrexate—testicular cancer	0.000562	0.000562	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—testicular cancer	0.000562	0.000562	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—testicular cancer	0.000558	0.000558	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methotrexate—testicular cancer	0.000557	0.000557	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—testicular cancer	0.000554	0.000554	CcSEcCtD
Fondaparinux sodium—Infection—Methotrexate—testicular cancer	0.000554	0.000554	CcSEcCtD
Fondaparinux sodium—Nausea—Etoposide—testicular cancer	0.000553	0.000553	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methotrexate—testicular cancer	0.000547	0.000547	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—testicular cancer	0.000547	0.000547	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Methotrexate—testicular cancer	0.000546	0.000546	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—testicular cancer	0.000544	0.000544	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methotrexate—testicular cancer	0.000541	0.000541	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00054	0.00054	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methotrexate—testicular cancer	0.000539	0.000539	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—testicular cancer	0.000531	0.000531	CcSEcCtD
Fondaparinux sodium—Anorexia—Methotrexate—testicular cancer	0.000531	0.000531	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—testicular cancer	0.00053	0.00053	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—testicular cancer	0.000526	0.000526	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—testicular cancer	0.000523	0.000523	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Fondaparinux sodium—Hypotension—Methotrexate—testicular cancer	0.000521	0.000521	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—testicular cancer	0.00052	0.00052	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—testicular cancer	0.000516	0.000516	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—testicular cancer	0.000513	0.000513	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—testicular cancer	0.000512	0.000512	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—testicular cancer	0.000511	0.000511	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—testicular cancer	0.000511	0.000511	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—testicular cancer	0.000509	0.000509	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—testicular cancer	0.000507	0.000507	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—testicular cancer	0.000504	0.000504	CcSEcCtD
Fondaparinux sodium—Insomnia—Methotrexate—testicular cancer	0.000504	0.000504	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—testicular cancer	0.000503	0.000503	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methotrexate—testicular cancer	0.0005	0.0005	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.0005	0.0005	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—testicular cancer	0.000497	0.000497	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Methotrexate—testicular cancer	0.000497	0.000497	CcSEcCtD
Fondaparinux sodium—Somnolence—Methotrexate—testicular cancer	0.000495	0.000495	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methotrexate—testicular cancer	0.000491	0.000491	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Methotrexate—testicular cancer	0.000484	0.000484	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000481	0.000481	CcSEcCtD
Fondaparinux sodium—Fatigue—Methotrexate—testicular cancer	0.00048	0.00048	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
Fondaparinux sodium—Pain—Methotrexate—testicular cancer	0.000477	0.000477	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—testicular cancer	0.000475	0.000475	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—testicular cancer	0.000473	0.000473	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—testicular cancer	0.000473	0.000473	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—testicular cancer	0.000472	0.000472	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—testicular cancer	0.000471	0.000471	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—testicular cancer	0.000469	0.000469	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—testicular cancer	0.000468	0.000468	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—testicular cancer	0.000467	0.000467	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—testicular cancer	0.000464	0.000464	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—testicular cancer	0.00046	0.00046	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methotrexate—testicular cancer	0.000459	0.000459	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—testicular cancer	0.000459	0.000459	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methotrexate—testicular cancer	0.000456	0.000456	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—testicular cancer	0.000453	0.000453	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00045	0.00045	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—testicular cancer	0.00045	0.00045	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
Fondaparinux sodium—Urticaria—Methotrexate—testicular cancer	0.000443	0.000443	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methotrexate—testicular cancer	0.000441	0.000441	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Methotrexate—testicular cancer	0.000441	0.000441	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—testicular cancer	0.000436	0.000436	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—testicular cancer	0.000429	0.000429	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—testicular cancer	0.000426	0.000426	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—testicular cancer	0.000425	0.000425	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000417	0.000417	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—testicular cancer	0.000416	0.000416	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—testicular cancer	0.000414	0.000414	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—testicular cancer	0.000413	0.000413	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—testicular cancer	0.000413	0.000413	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methotrexate—testicular cancer	0.000411	0.000411	CcSEcCtD
Fondaparinux sodium—Asthenia—Methotrexate—testicular cancer	0.0004	0.0004	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000395	0.000395	CcSEcCtD
Fondaparinux sodium—Pruritus—Methotrexate—testicular cancer	0.000394	0.000394	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—testicular cancer	0.000384	0.000384	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—testicular cancer	0.000381	0.000381	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—testicular cancer	0.000381	0.000381	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methotrexate—testicular cancer	0.000381	0.000381	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—testicular cancer	0.000374	0.000374	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—testicular cancer	0.000369	0.000369	CcSEcCtD
Fondaparinux sodium—Dizziness—Methotrexate—testicular cancer	0.000369	0.000369	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—testicular cancer	0.000357	0.000357	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—testicular cancer	0.000356	0.000356	CcSEcCtD
Fondaparinux sodium—Vomiting—Methotrexate—testicular cancer	0.000354	0.000354	CcSEcCtD
Fondaparinux sodium—Rash—Methotrexate—testicular cancer	0.000351	0.000351	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methotrexate—testicular cancer	0.000351	0.000351	CcSEcCtD
Fondaparinux sodium—Headache—Methotrexate—testicular cancer	0.000349	0.000349	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—testicular cancer	0.000346	0.000346	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—testicular cancer	0.000345	0.000345	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—testicular cancer	0.000341	0.000341	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—testicular cancer	0.000332	0.000332	CcSEcCtD
Fondaparinux sodium—Nausea—Methotrexate—testicular cancer	0.000331	0.000331	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—testicular cancer	0.00033	0.00033	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—testicular cancer	0.000329	0.000329	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—testicular cancer	0.000329	0.000329	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—testicular cancer	0.000327	0.000327	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—testicular cancer	0.000319	0.000319	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—testicular cancer	0.00031	0.00031	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—testicular cancer	0.000307	0.000307	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—testicular cancer	0.000302	0.000302	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—testicular cancer	0.000287	0.000287	CcSEcCtD
